Cooperative Agreement AIDOAAA1600048

This Project Grant award of $699,339.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to study the transmission dynamics of dengue and Zika viruses across diverse communities in northwestern coastal Ecuador. The study aims to characterize how changes in environment, social networks, and vector populations influence regional virus transmission patterns. Key activities include...

This five-year $1,355,000 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) aims to enhance the capacity of Central America and the Dominican Republic to prevent, detect, and respond to infectious disease threats. The initiative will strengthen regional leadership, technical capacity, and multi-sectoral collaboration to address cross-border infectious disease challenges. The primary...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to decipher the role of the chemokine receptor CCR5 in protecting against flavivirus infections during pregnancy. The $3,021,038 grant, awarded on September 2, 2025, will fund a study to investigate the mechanisms by which CCR5 provides neuroprotection against West Nile virus, Zika virus, and other...

This $116,766 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research at Rutgers, The State University to define the long-term neurological consequences of asymptomatic Zika virus (ZIKV) infection. The research team has developed an immunocompetent mouse model of systemic ZIKV infection in which infected animals do not display...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $781,718 Project Grant through its Allergy and Infectious Diseases Research program (CFDA 93.855) to Loyola University of Chicago to develop a novel T cell-based vaccine to prevent Dengue and Zika virus infections. The 5-year project aims to create a vaccine that induces cytotoxic T cells targeting the Zika virus non-structural protein 3, without causing antibody-dependent enhancement observed with vaccines targeting the...

This Project Grant award of $2,536,503 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand how the ability of Aedes aegypti mosquitoes to tolerate desiccation affects their potential as disease vectors. The research aims to identify genetic mechanisms linking desiccation tolerance to susceptibility to Zika, Chikungunya, and Dengue viruses in the mosquito midgut. Key...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research investigating the role of the MERTK receptor tyrosine kinase in cognitive and behavioral dysfunction in mice with congenital Zika virus infection. The $234,359 award, effective from January 15, 2025 through December 31, 2029, will enable researchers at the Washington...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $302,537 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Synvect, Inc. to finalize the development and commercialization of their NextGenSIT technology for Aedes aegypti mosquito control. The objectives of this grant are to: 1) finalize the genetic components for producing competitive, sterile male Ae. aegypti mosquitoes using CRISPR gene knockouts; 2) develop and validate...

The Cooperative Agreement award CK25-182 titled "PUERTO RICO ENHANCED SURVEILLANCE AND CONTROL OF ENDEMIC AND EMERGING ARBOVIRUSES" was provided by the Centers for Disease Control and Prevention (CDC) under the Prevention of Disease, Disability, and Death by Infectious Diseases program (CFDA 93.084). The $775,000.00 award to the Ponce Medical School Foundation Inc. aims to enhance surveillance and control efforts for endemic and emerging arboviral diseases in Puerto Rico over the...

The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a $133,223 Project Grant to the University of Washington to characterize host proteins that restrict Zika virus (ZIKV). The project aims to identify host genes, including both interferon-stimulated genes and non-interferon-stimulated genes, that contribute to the innate immune system's ability to restrict ZIKV replication in human...